For research use only. Not for therapeutic Use.
XZ45（Cat No.:I038497）is a small molecule compound that has shown potential as a therapeutic agent in cancer treatment. It is primarily studied for its ability to inhibit key enzymes or signaling pathways involved in tumor cell proliferation, survival, and metastasis. XZ45 works by targeting specific molecular mechanisms that drive the growth of cancer cells, thereby suppressing tumor progression. Early preclinical studies suggest that XZ45 may be effective against certain cancer types, although more research is needed to evaluate its safety, efficacy, and potential use in clinical oncology settings.
| Catalog Number | I038497 |
| Synonyms | XZ45; XZ-45; XZ 45 |
| Molecular Formula | C14H12N2O5 |
| Purity | 98% |
| Solubility | Soluble in DMSO |
| Appearance | Solid powder |
| Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
| IUPAC Name | 2,3-dihydroxy-N'-(2-hydroxybenzoyl)benzohydrazide |
| InChI | InChI=1S/C14H12N2O5/c17-10-6-2-1-4-8(10)13(20)15-16-14(21)9-5-3-7-11(18)12(9)19/h1-7,17-19H,(H,15,20)(H,16,21) |
| InChIKey | DNCBPZLOUZEIIO-UHFFFAOYSA-N |
| SMILES | C1=CC=C(C(=C1)C(=O)NNC(=O)C2=C(C(=CC=C2)O)O)O |
